Valuation: Quidel Corporation

Market Cap 763M 661M 625M 565M 1.06B 73.15B 1.07B 7.45B 2.87B 37.09B 2.86B 2.8B 118B P/E 2026 *
-2.7x
P/E 2027 * -4.01x
Enterprise Value 3.48B 3.01B 2.85B 2.58B 4.84B 333B 4.87B 33.97B 13.07B 169B 13.05B 12.76B 539B EV / Sales 2026 *
1.37x
EV / Sales 2027 * 1.31x
Free-Float
99.11%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 61 2024-05-05
Director of Finance/CFO 48 2026-07-05
Chief Operating Officer 57 2024-11-14
Director TitleAgeSince
Chairman 72 2022-12-10
Director/Board Member 71 2021-12-31
Director/Board Member 82 1992-12-31
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 763M
+4.70%+0.21%+20.54%-31.54% 16.33B
+6.56%+16.82%-30.07%+54.23% 1.77B
-0.73%-2.78%-29.01%+17.73% 892M
-1.21%-18.16%-62.14%-85.54% 763M
+0.14%-0.03%+61.02%-1.94% 778M
-1.13%-6.14%-39.43%-50.07% 638M
-0.49%-8.87%-42.60%-52.86% 569M
-4.24%+1.93%-46.24%-41.77% 444M
0.00%-0.74%-8.52%-9.24% 393M
Average +0.39%-4.35%-19.61%-22.33% 2.51B
Weighted average by Cap. +3.48%-2.31%+8.11%-24.55%

Financials

2026 *2027 *
Net sales 2.54B 2.2B 2.08B 1.89B 3.54B 244B 3.57B 24.87B 9.57B 124B 9.56B 9.35B 395B 2.59B 2.24B 2.12B 1.92B 3.61B 249B 3.63B 25.33B 9.75B 126B 9.73B 9.52B 402B
Net income -282M -244M -231M -209M -392M -27.01B -395M -2.75B -1.06B -13.69B -1.06B -1.03B -43.67B -190M -165M -156M -141M -265M -18.25B -267M -1.86B -716M -9.26B -715M -699M -29.52B
Net Debt 2.71B 2.35B 2.22B 2.01B 3.78B 260B 3.8B 26.51B 10.2B 132B 10.19B 9.96B 421B 2.62B 2.27B 2.15B 1.95B 3.65B 252B 3.68B 25.65B 9.87B 128B 9.86B 9.64B 407B
Logo Quidel Corporation
QuidelOrtho Corporation provides in vitro diagnostics, developing and manufacturing intelligent solutions. The Company specializes in immunoassay and molecular testing, clinical chemistry and transfusion medicine. Its business units include labs, molecular diagnostics, point of care and transfusion medicine. Under the labs business unit, its product categories include virology & bioassays, specialty products, VITROS platform and immunodiagnostics. Under the molecular diagnostics business unit, its product categories include Lyra, Solana and Savanna. Under the point of care business unit, its product categories include rapid immunoassay and cardiometabolic immunoassay. Under the transfusion medicine business unit, its product categories include immunohematology and donor screening. It provides diagnostic testing solutions under various brand names, including AdenoPlus, BIOVUE, FreshCells, InflammaDry, Lyra, MeterPro, MicroVue, Ortho, Ortho Clinical Diagnostics, Ortho Optix and others.
Employees
6,500
Trader
Investor
Global
Quality
ESG MSCI
-
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!